Skip to main content
CDC Website

Hepatitis

Hepatitis Awareness Month Toolkit 2023

May is Hepatitis Awareness Month (HAM) and May 19th is Hepatitis Testing Day. Use the following social media toolkit to amplify hepatitis awareness!

Injection Drug Use (IDU) Infographic

This infographic discusses how in 2018, injection drug use (IDU) was highest among men (21%),

World Hepatitis Summit 2022

This report summarizes that the third WHS was held as a predominately virtual event in 2022, with a small in-person hub at the World Health Organization in Geneva, with the theme of “Achieving the elimination of viral hepatitis within evolving health systems”. The programme introduced the new Global Health Sector Strategy (2022-2030) and explored topics across the cascade of care for hepatitis A, B, C, D and E, including barriers such as stigma and discrimination and innovations, like the potential for a functional cure for hepatitis B.

2021 Viral Hepatitis Surveillance Status Report

This document discusses how an estimated 2.4 million people in the U.S. are living with hepatitis C infection, while up to 1.59 million people could be living with hepatitis B in the U.S. The need for expanded, standardized, and reliable viral hepatitis surveillance continues to impact public health efforts, resources, and response across the U.S. to this epidemic.

Long-Acting Technologies Trials Tracker for Hepatitis C, Opioid Use and Overdose Prevention Therapy, and Malaria

The Unitaid-funded LONGEVITY project aims to develop long-acting formulations for malaria and latent tuberculosis (TB) prevention and a single-injection cure for hepatitis C virus (HCV) for low- and middle-income countries, as these diseases disproportionately affect children, poor and marginalized communities, people who use drugs, and people living with HIV.

2022 Viral Hepatitis National Progress Report

The Viral Hepatitis National Progress Report provides information on progress in the implementation of recommended interventions and the impact these interventions are having on prevention of viral hepatitis transmission, disease, and associated mortality.